NYSE:NTR - Nutrien Stock Price, Forecast & News

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien declared a quarterly dividend on Tuesday, July 30th. Investors of record on Monday, September 30th will be paid a dividend of $0.45 per share on Thursday, October 17th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 3.85%. The ex-dividend date of this dividend is Friday, September 27th. This is an increase from Nutrien's previous quarterly dividend of $0.43. View Nutrien's Dividend History.

Nutrien Ltd (NYSE:NTR) issued its earnings results on Monday, November, 4th. The company reported $0.24 EPS for the quarter, missing analysts' consensus estimates of $0.36 by $0.12. The business earned $4.13 billion during the quarter, compared to analyst estimates of $4.02 billion. Nutrien had a return on equity of 6.49% and a net margin of 20.95%. Nutrien's quarterly revenue was up 3.6% on a year-over-year basis. During the same quarter last year, the company earned $0.47 EPS. View Nutrien's Earnings History.

Nutrien is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Nutrien.

15 brokers have issued 1-year price targets for Nutrien's shares. Their forecasts range from $50.00 to $70.00. On average, they expect Nutrien's stock price to reach $60.53 in the next twelve months. This suggests a possible upside of 29.4% from the stock's current price. View Analyst Price Targets for Nutrien.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 3 hold ratings, 11 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Nutrien.

Media headlines about NTR stock have been trending very negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Nutrien earned a media sentiment score of -3.6 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Nutrien.

Nutrien saw a drop in short interest in October. As of October 31st, there was short interest totalling 3,960,000 shares, a drop of 17.7% from the September 30th total of 4,810,000 shares. Based on an average daily volume of 1,080,000 shares, the short-interest ratio is currently 3.7 days. Approximately 0.7% of the company's shares are sold short. View Nutrien's Current Options Chain.

Some companies that are related to Nutrien include CF Industries (CF), Mosaic (MOS), Israel Chemicals (ICL), Scotts Miracle-Gro (SMG), Nufarm (NUF), American Vanguard (AVD), CVR Partners (UAN), Calyxt (CLXT), Marrone Bio Innovations (MBII), Wynnstay Group (WYN), Arcadia Biosciences (RKDA), Evogene (EVGN), SenesTech (SNES), China Green Agriculture (CGA) and Eden Research (EDEN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Cimarex Energy (XEC), JPMorgan Chase & Co. (JPM), General Electric (GE), Micron Technology (MU), CVS Health (CVS), Verizon Communications (VZ), Cisco Systems (CSCO), Wells Fargo & Co (WFC) and Intel (INTC).

Nutrien's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Beutel Goodman & Co Ltd. (2.30%), CIBC Asset Management Inc (1.25%), Great West Life Assurance Co. Can (0.96%), Boston Partners (0.65%), Cambiar Investors LLC (0.48%) and Sumitomo Mitsui Trust Holdings Inc. (0.43%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Cambiar Investors LLC, Millennium Management LLC, Beutel Goodman & Co Ltd., Addenda Capital Inc., CWM LLC, QV Investors Inc. and Russell Investments Group Ltd..

NTR stock was purchased by a variety of institutional investors in the last quarter, including Phoenix Holdings Ltd., Ilmarinen Mutual Pension Insurance Co, TIAA FSB, Great West Life Assurance Co. Can, Alberta Investment Management Corp, Zurcher Kantonalbank Zurich Cantonalbank, Parametric Portfolio Associates LLC and Man Group plc.

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $46.77.

Nutrien has a market capitalization of $26.79 billion and generates $19.64 billion in revenue each year. The company earns $3.57 billion in net income (profit) each year or $2.69 on an earnings per share basis. Nutrien employs 20,300 workers across the globe.View Additional Information About Nutrien.

The official website for Nutrien is http://www.nutrien.com/.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]